Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company focusing on therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. The company's therapeutic approach, Characterized Oral Desensitization ImmunoTherapy (CODITTM), is designed to desensitize patients to food allergens and thereby reduce the risk of having an allergic reaction upon accidental exposure, or reduce symptom severity should an allergic reaction occur. The company's primary CODIT product candidate, AR101, is an investigational biologic for the treatment of patients 4-17 years of age with peanut allergy.
  • TickerAIMT
  • ISINUS00900T1079
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

Liana Moussatos ...
  • Shveta Dighe

AR101/Peanut Allergy: MAA Submission Mid:19 & FDA AdComm on Sept 13

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

Liana Moussatos ...
  • Shveta Dighe

AR101/Peanut Allergy: MAA Submission Mid:19 & FDA AdComm on Sept 13

Liana Moussatos ...
  • Shveta Dighe

Q1: Strong Cash Position; Next in Mid:19- Submission of AR101 MAA

Three Directors sold after exercising options/sold 157,425 shares at between 33.545USD and 34.444USD.

Three Directors at Aimmune Therapeutics Inc sold after exercising options/sold 157,425 shares at between 33.545USD and 34.444USD. The significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where tra...

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

ValuEngine Rating and Forecast Report for AIMT

ResearchPool Subscriptions

Get the most out of your insights

Get in touch